News

Latest Research Results of CSPC's Duomeisu Presented at SABCS

February 21, 2024

Recently, the 2023 San Antonio Breast Cancer Symposium (SABCS) was held in San Antonio, Texas, USA. SABCS is one of the largest and most prestigious scientific gatherings in breast cancer research, aiming to transmit the latest research results, clinical practical experience, and technological innovations in breast cancer.

The final results from the "Clinical Study on Pegylated Liposomal Doxorubicin (PLD)/Cyclophosphamide Sequential Taxanes in Combination with Whole-Course Dual-Target (HP) Neoadjuvant Treatment for HER2-Positive Breast Cancer", jointly conducted by CSPC and the team of Professor Liu Qiang from Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, were presented in poster at the meeting.

Copyright © CSPC Pharmaceutical Group Co., Ltd. All Rights Reserved |

Wechat